Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHONY.L Regulatory News (HONY)

  • There is currently no data for HONY

Share Buy-Back Programme

10 Aug 2020 14:23

RNS Number : 6861V
Honeycomb Investment Trust PLC
10 August 2020
Β 

10 August 2020

Honeycomb Investment Trust plc("Honeycomb" or the "Company")

Share Buy-Back Programme

Honeycomb Investment Trust plcΒ announcesΒ the implementation of a share buyback programme, pursuant to the authority granted at the Company's Annual General Meeting held on 26 June 2020, to purchase the Company's ordinary shares of Β£0.01 each (the "Ordinary Shares"), commencing on 10 August 2020 (the "Buyback Programme"). The Buyback Programme is expected to end no later than 31 August 2021. If the Buyback Programme is subsequently extended or increased in scale, an announcement will be made at the relevant time.

In accordance with the resolution passed at the Company's Annual General Meeting held on 26 June 2020, purchases can be made pursuant to the Buyback Programme provided, inter alia, that:

(A) the maximum number of Ordinary Shares that may be purchased is 5,583,762 Ordinary Shares;

(B) the minimum price (exclusive of expenses) which may be paid per Ordinary Share is Β£0.01; and

(C) the maximum price (exclusive of expenses) which may be paid per Ordinary Share is the higher of (a) an amount equal to 105% of the average of the mid-market values of the Ordinary Shares for the five business days immediately preceding the day on which the Company contracts to purchase the relevant Ordinary Shares; and (b) an amount equal to the higher of the price of the last independent trade of an Ordinary Share and the highest current independent purchase bid at the time on the trading venue on which the purchase is carried out.

The Company has 39,449,919 Ordinary Shares in issue, of which 2,935,000 Ordinary Shares are held in treasury. Ordinary Shares purchased by the Company pursuant to the Buyback Programme will be held in treasury.

The Board believes that implementation of an active share price discount management strategy through this Buyback Programme works in the best interest of the Company's shareholders and will be value accretive to the Company.

Shareholders should be aware that a purchase of Ordinary Shares by the Company on any trading day may represent a significant proportion of the daily trading volume in the Ordinary Shares and could exceed 25 per cent of the average daily trading volume of the preceding 20 business days.

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 ("MAR"), and is disclosed in accordance with the Company's obligations under Article 17 of MAR.

The person responsible for releasing this announcement on behalf of the Company is Robert Sharpe, Chairman.

Pollen Street Capital - Investment Manager

Chris Palmer / Matthew Potter: +44 (0)20 3728 6740

Liberum Capital Limited - Broker

Chris Clarke: +44 (0)20 3100 2000

Camarco - Investor Relations

Ed Gascoigne-Pees / Jennifer Renwick: +44 (0)20 3757 4994

Link Company Matters Limited - Corporate Secretary

Paul Johnston : +44 (0)20 7954 9552

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
Β 
END
Β 
Β 
POSFLFFVTIIILII
Date   Source Headline
21st Sep 20187:01 amRNSAugust Factsheet
21st Sep 20187:00 amRNSNet Asset Value
5th Sep 20187:00 amRNSDividend Declaration
5th Sep 20187:00 amRNSHalf-year Report 2018
21st Aug 20187:00 amRNSMonthly Update - 31st July 2018
21st Aug 20187:00 amRNSNet Asset Value - 31st July 2018
20th Jul 20187:00 amRNSMonthly Update - Factsheet June 30th 2018
20th Jul 20187:00 amRNSNet Asset Value - June 30th 2018
21st Jun 20183:17 pmRNSNet Asset Value - 31st May 2018 - Replacement
21st Jun 20187:00 amRNSMonthly Update - May 2018
21st Jun 20187:00 amRNSNet Asset Value(s)
8th Jun 20185:42 pmRNSResult of AGM
25th May 20185:29 pmRNSNet Asset Value - 30 April 2018 - Replacement
21st May 20187:00 amRNSNet Asset Value - 30 April 2018
21st May 20187:00 amRNSMonthly Update - 30 April 2018
9th May 20184:28 pmRNSAGM and Financial Statements Notification-Dec 2017
2nd May 20187:00 amRNSHolding(s) in Company
30th Apr 20187:00 amRNSAnnual Report and Audited Financial Statements
25th Apr 20187:00 amRNSHolding(s) in Company - TR1 Announcement
19th Apr 20184:30 pmRNSResult of Placing
19th Apr 20187:00 amRNSProposed Placing
16th Apr 20187:25 amRNSChange of Registered Office
12th Apr 20187:00 amRNSMonthly Update - March 2018
12th Apr 20187:00 amRNSDividend Declaration
12th Apr 20187:00 amRNSNet Asset Value - March 2018
5th Apr 201810:00 amRNSHolding(s) in Company - TR1 Notification
21st Mar 20187:00 amRNSMonthly update - February 28th 2018
21st Mar 20187:00 amRNSNet Asset Value - February 2018
8th Mar 20184:00 pmRNSSupplementary Prospectus
21st Feb 20187:00 amRNSMonthly Update - 31st January 2018
21st Feb 20187:00 amRNSNet Asset Value(s)
21st Feb 20187:00 amRNSDividend Declaration
23rd Jan 20187:00 amRNSHolding(s) in Company - TR1 Notification
22nd Jan 20187:00 amRNSMonthly Update - December 2017
22nd Jan 20187:00 amRNSNet Asset Value(s)
21st Dec 20177:00 amRNSMonthly Update - November
21st Dec 20177:00 amRNSNet Asset Value(s)
28th Nov 20177:00 amRNSHolding(s) in Company - TR-1 Notification
21st Nov 20172:20 pmRNSDividend Declaration - Replacement
21st Nov 20177:00 amRNSMonthly Update - October 2017
21st Nov 20177:00 amRNSDividend Declaration
21st Nov 20177:00 amRNSNet Asset Value(s) - October 2017
16th Nov 20177:00 amRNSHolding(s) in Company - TR-1 Notification
20th Oct 20177:00 amRNSNet Asset Value - September 2017
20th Oct 20177:00 amRNSMonthly Update - September 2017
21st Sep 20177:00 amRNSMonthly update - August 2017
21st Sep 20177:00 amRNSNet Asset Value - August 2017
31st Aug 20177:00 amRNSDividend Declaration - Q2 2017
31st Aug 20177:00 amRNSFinancial Statement Announcement
31st Aug 20177:00 amRNSHalf-year Report 2017

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.